These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 19016731

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
    Schweighofer CD, Ritgen M, Eichhorst BF, Busch R, Abenhardt W, Kneba M, Hallek M, Wendtner CM.
    Br J Haematol; 2009 Jan; 144(1):95-8. PubMed ID: 19016732
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia.
    Cortelezzi A, Pasquini MC, Sarina B, Bertani G, Grifoni F, Colombi M, Lambertenghi Deliliers G.
    Haematologica; 2005 Mar; 90(3):410-2. PubMed ID: 15749678
    [Abstract] [Full Text] [Related]

  • 31. Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
    Saadeh CE, Srkalovic G.
    Pharmacotherapy; 2008 Feb; 28(2):281-4. PubMed ID: 18225973
    [Abstract] [Full Text] [Related]

  • 32. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.
    Moreton P, Kennedy B, Lucas G, Leach M, Rassam SM, Haynes A, Tighe J, Oscier D, Fegan C, Rawstron A, Hillmen P.
    J Clin Oncol; 2005 May 01; 23(13):2971-9. PubMed ID: 15738539
    [Abstract] [Full Text] [Related]

  • 33. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
    Rai KR, Freter CE, Mercier RJ, Cooper MR, Mitchell BS, Stadtmauer EA, Santábarbara P, Wacker B, Brettman L.
    J Clin Oncol; 2002 Sep 15; 20(18):3891-7. PubMed ID: 12228210
    [Abstract] [Full Text] [Related]

  • 34. Alemtuzumab for B-cell chronic lymphocytic leukemia.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2005 Mar 15; (66):1-4. PubMed ID: 15806747
    [Abstract] [Full Text] [Related]

  • 35. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
    Alinari L, Lapalombella R, Andritsos L, Baiocchi RA, Lin TS, Byrd JC.
    Oncogene; 2007 May 28; 26(25):3644-53. PubMed ID: 17530018
    [Abstract] [Full Text] [Related]

  • 36. Strategies in the management of alemtuzumab-related side effects.
    Osterborg A, Karlsson C, Lundin J, Kimby E, Mellstedt H.
    Semin Oncol; 2006 Apr 28; 33(2 Suppl 5):S29-35. PubMed ID: 16720201
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
    Fiegl M, Falkner F, Steurer M, Zojer N, Hopfinger G, Haslbauer F, Winder G, Voskova D, Andel J, Lang A, Brychtova Y, Mayer J, Greil R, Gastl G, Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, Czech Leukemia Study Group for Life, CELL.
    Ann Hematol; 2011 Sep 28; 90(9):1083-91. PubMed ID: 21350830
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab.
    Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, Solano C, de la Cámara R, Rosell AI, Varela R, García MD, González-Barca E, López J, Pérez E, Ferrer S, Casado LF, Vázquez L, Villalón L, García-Marco JA.
    Expert Rev Hematol; 2011 Feb 28; 4(1):9-16. PubMed ID: 21322774
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.